Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action

<div><i>Signalling pathways in colorectal cancer pathogenesis (adapted from [<a href="/journals/bmri/2018/4154185/#B12">168</a>])</i>. (EGFR: epidermal growth factor receptor, TGF<i>β</i> R1/2: transforming growth factor, beta receptor 1/2, EMT: epithelial-mesenchymal transition, ICAMs: intercellular adhesive molecules, MMPs: matrix metallopeptidases).</div>

BioMed Research International

fig3

Figure 3

Figure 3: Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action 